Abstract:Spinocerebellar ataxia subtype 37 (SCA37) is a rare disease originally identified in ataxia patients from the Iberian Peninsula with a pure cerebellar syndrome. SCA37 patients carry a pathogenic intronic (ATTTC)n repeat insertion flanked by two polymorphic (ATTTT)n repeats in the Disabled-1 (DAB1) gene leading to cerebellar dysregulation. Herein, we determine the precise configuration of the pathogenic 5ʹ(ATTTT)n–(ATTTC)n–3ʹ(ATTTT)n SCA37 alleles by CRISPR–Cas9 and long-read nanopore sequencing, reveal their epigenomic signatures in SCA37 lymphocytes, fibroblasts, and cerebellar samples, and establish new molecular and clinical correlations. The 5ʹ(ATTTT)n–(ATTTC)n–3ʹ(ATTTT)n pathogenic allele configurations revealed repeat instability and differential methylation signatures. Disease age of onset negatively correlated with the (ATTTC)n, and positively correlated with the 3ʹ(ATTTT)n. Geographic origin and gender significantly correlated with age of onset. Furthermore, significant predictive regression models were obtained by machine learning for age of onset and disease evolution by considering gender, the (ATTTC)n, the 3ʹ(ATTTT)n, and seven CpG positions differentially methylated in SCA37 cerebellum. A common 964-kb genomic region spanning the (ATTTC)n insertion was identified in all SCA37 patients analysed from Portugal and Spain, evidencing a common origin of the SCA37 mutation in the Iberian Peninsula originating 859 years ago (95% CI 647–1378). In conclusion, we demonstrate an accurate determination of the size and configuration of the regulatory 5ʹ(ATTTT)n–(ATTTC)n–3ʹ(ATTTT)n repeat tract, avoiding PCR bias amplification using CRISPR/Cas9-enrichment and nanopore long-read sequencing, resulting relevant for accurate genetic diagnosis of SCA37. Moreover, we determine novel significant genotype–phenotype correlations in SCA37 and identify differential cerebellar allele-specific methylation signatures that may underlie DAB1 pathogenic dysregulation.

Two more families supporting the existence of monogenic spinocerebellar ataxia 48

Case Series of Cerebellar Ataxia with Tremor Due to Heterozygous STUB1 Variants (SCA48) without TBP Expansions: Further Evidence for SCA48 as a Monogenic Disease

A Chinese Family with Digenic TBP/STUB1 Spinocerebellar Ataxia

Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

Early-onset phenotype in a patient with an intermediate allele and a large SCA1 expansion: a case report

Autosomal dominant cerebellar ataxias: new genes and progress towards treatments

Spinocerebellar Ataxia Type 28 in a Chinese Pedigree

A Spinocerebellar Ataxia Family with Expanded Alleles in the Tata-Binding Protein Gene and Ataxin-3 Gene

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

Rare association between spinocerebellar ataxia and amyotrophic lateral sclerosis: a case series

Molecular Genetics of a Chinese Family with Spinocerebellar Ataxia

Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort

Molecular Genetic Analysis of a New Form of Spinocerebellar Ataxia in a Chinese Han Family.

Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy

Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view

Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus

Somatic instability of the FGF14 -SCA27B GAA•TTC repeat reveals a marked expansion bias in the cerebellum

Spinocerebellar Ataxia 2 in a Family with Different Phenotypes: Two Case Reports.

Novel genotype–phenotype correlations, differential cerebellar allele-specific methylation, and a common origin of the (ATTTC)n insertion in spinocerebellar ataxia type 37

Somatic instability of the -SCA27B GAA·TTC repeat reveals a marked expansion bias in the cerebellum

Inherited Spinocerebellar Ataxia Segregates with Intra-Familial Genetic Heterogeneity in a Consanguineous Pakistani Family: A Report of a Potential Novel Candidate Gene.